,myxopyronin

Alexander F Kiefer1,2,3,4, Alexander Voltz1,2,3,4,5, Domen Scherzer1,2,3,4,5

  • 1Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Campus E8.1, 66123 Saarbrücken, Germany.

JACS Au
|December 26, 2025
PubMed
概括

新型抗生素前体,myxopyronins,是使用突变合成生成的. 一种新的三甲基改性类似物显示出对耐药细菌 (如Mycobacterium tuberculosis) 的强大活性,为抗生素耐药性提供了希望.